Macrophage-directed Therapies Summit 2020
October 27 - 29, 2020 - MA USHanson Wade
info@hansonwade.com
Phone:(+1) 617 455 4188
With the explosive excitement and clinical proof of concept utilizing CD47 approaches, 2020 is the year for macrophage development, as we witness greater interest and investment in new work on novel macrophage targets outside of CD47. The Macrophage-directed Therapies Summit is focused on optimizing the potential of macrophage therapies, through direct utilization of cells or small molecule approaches to target and stimulate macrophage cells in vivo for oncological indications and beyond. Join us this October as the trailblazers of macrophage therapeutic development, from the likes of Carisma Therapeutics, Faron Pharmaceuticals, and Verseau Therapeutics come together to advance the fundamental understanding of macrophage biology, avoiding on-target toxicities and the emerging field of macrophage cellular immunotherapy. Early booking and Academic discounts available - see website for more details. https://macrophage-directed-therapies.com/ Contact: info@hansonwade.com +1 617 455 4188